Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
NCT06348797
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Small Cell Lung Cancer Extensive Stage
Interventions
DRUG:
α-PD-L1/4-1BB DLL3 CAR-T (BHP01)
Sponsor
Sichuan University
Collaborators
[object Object]